Mobia Medical (NASDAQ:MOBI) Director Casey Tansey Acquires 15,821 Shares

Mobia Medical, Inc. (NASDAQ:MOBI) Director Casey Tansey acquired 15,821 shares of the business’s stock in a transaction on Friday, August 14th. The shares were bought at an average price of $11.66 per share, with a total value of $184,472.86. Following the completion of the transaction, the director directly owned 284,725 shares of the company’s stock, valued at approximately $3,319,893.50. The trade was a 5.88% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Mobia Medical Trading Down 0.2%

Shares of NASDAQ:MOBI traded down $0.02 during trading on Monday, reaching $11.74. 98,126 shares of the stock were exchanged, compared to its average volume of 92,796. Mobia Medical, Inc. has a 12 month low of $10.19 and a 12 month high of $15.29. The company’s 50-day moving average is $12.42. The company has a debt-to-equity ratio of 0.04, a quick ratio of 12.80 and a current ratio of 13.28. The company has a market cap of $390.82 million and a price-to-earnings ratio of -0.61.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The company had revenue of $13.51 million during the quarter. The firm’s quarterly revenue was up 102.4% on a year-over-year basis. On average, sell-side analysts expect that Mobia Medical, Inc. will post -2.76 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. JPMorgan Chase & Co. raised their price target on shares of Mobia Medical from $15.00 to $17.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Wolfe Research started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They issued an “outperform” rating for the company. Zacks Research upgraded shares of Mobia Medical to a “hold” rating in a research report on Wednesday, June 3rd. Wall Street Zen raised shares of Mobia Medical from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. Finally, The Goldman Sachs Group assumed coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $31.00 price target for the company. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Mobia Medical presently has an average rating of “Moderate Buy” and an average target price of $20.75.

About Mobia Medical

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.